Published in Semin Immunopathol on January 10, 2017
Predictive value of serum ALT and T-cell receptor beta variable chain for HBeAg seroconversion in chronic hepatitis B patients during tenofovir treatment. Medicine (Baltimore) (2017) 0.75
Cancer and autoimmunity. Semin Immunopathol (2017) 0.75
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54
T-cell antigen receptor genes and T-cell recognition. Nature (1988) 16.77
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (1991) 14.57
PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature (2014) 10.39
Adaptive immunity maintains occult cancer in an equilibrium state. Nature (2007) 8.14
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity (2008) 5.35
Neoantigens in cancer immunotherapy. Science (2015) 5.16
The concept of immunological surveillance. Prog Exp Tumor Res (1970) 4.76
Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med (1993) 4.58
A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol (1993) 4.44
A central role for central tolerance. Annu Rev Immunol (2006) 4.31
Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell (2015) 4.16
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells. J Exp Med (2011) 4.02
Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J Exp Med (2011) 3.85
Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res (2009) 3.83
The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin Orthop Relat Res (1991) 3.79
T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today (1995) 3.60
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med (2008) 3.48
Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat Rev Immunol (2008) 2.98
Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see). Nat Rev Immunol (2014) 2.97
Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes. Genome Res (2011) 2.94
STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity (2014) 2.86
Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients. Sci Transl Med (2014) 2.50
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients. Nat Med (2016) 2.36
Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells. Cell (1989) 2.31
The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol (1990) 2.08
Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy. J Immunother (2004) 1.99
Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response. Sci Transl Med (2014) 1.80
TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients. Oncoimmunology (2012) 1.78
Immunosequencing: applications of immune repertoire deep sequencing. Curr Opin Immunol (2013) 1.76
Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Eur J Immunol (1992) 1.75
IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling. Nat Commun (2013) 1.71
CTLA4 blockade broadens the peripheral T-cell receptor repertoire. Clin Cancer Res (2014) 1.66
Diversity and clonal selection in the human T-cell repertoire. Proc Natl Acad Sci U S A (2014) 1.63
Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions. Clin Cancer Res (2014) 1.56
Antigen receptor allelic exclusion: an update and reappraisal. J Immunol (2010) 1.54
Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue. Cancer Immunol Immunother (2013) 1.53
Murine thymic selection quantified using a unique method to capture deleted T cells. Proc Natl Acad Sci U S A (2013) 1.52
Dissection of T-cell antigen specificity in human melanoma. Cancer Res (2012) 1.52
Different affinity windows for virus and cancer-specific T-cell receptors: implications for therapeutic strategies. Eur J Immunol (2012) 1.41
Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines. Clin Cancer Res (2011) 1.40
TCR dynamics on the surface of living T cells. Int Immunol (2001) 1.39
Characterization of TCR gene rearrangements during adult murine T cell development. J Immunol (1999) 1.39
High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer. J Pathol (2013) 1.31
Tertiary lymphoid structures in cancer and beyond. Trends Immunol (2014) 1.23
Excess cancers among HIV-infected people in the United States. J Natl Cancer Inst (2015) 1.19
Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution. Cell Metab (2016) 1.14
BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes. Oncoimmunology (2013) 1.13
Pairing of T-cell receptor chains via emulsion PCR. Eur J Immunol (2013) 1.12
Transcriptional control of t lymphocyte differentiation. Stem Cells (2001) 1.12
Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas. J Pathol (2013) 1.09
High-throughput pairing of T cell receptor α and β sequences. Sci Transl Med (2015) 1.08
Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients. Oncoimmunology (2012) 1.05
Landscape of tumor-infiltrating T cell repertoire of human cancers. Nat Genet (2016) 1.05
Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance. Cancer Res (2006) 1.05
tcR: an R package for T cell receptor repertoire advanced data analysis. BMC Bioinformatics (2015) 1.01
TCR repertoires of intratumoral T-cell subsets. Immunol Rev (2014) 1.00
Pre-TCR ligand binding impacts thymocyte development before αβTCR expression. Proc Natl Acad Sci U S A (2015) 0.96
The immune contexture of primary and metastatic human tumours. Curr Opin Immunol (2014) 0.96
Clonotypic Diversification of Intratumoral T Cells Following Sipuleucel-T Treatment in Prostate Cancer Subjects. Cancer Res (2016) 0.95
Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma. J Clin Invest (1996) 0.94
T-cell receptor beta variable region diversity in melanoma metastases after interleukin 2-based immunotherapy. Clin Cancer Res (1996) 0.90
In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites. Proc Natl Acad Sci U S A (1997) 0.90
Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastoma. Clin Cancer Res (2012) 0.88
Combining next-generation sequencing and immune assays: a novel method for identification of antigen-specific T cells. PLoS One (2013) 0.88
Immune surveillance of unhealthy cells by natural killer cells. Cold Spring Harb Symp Quant Biol (2013) 0.86
Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencing. Oncoimmunology (2015) 0.86
Advances in Cancer Immunotherapy in Solid Tumors. Cancers (Basel) (2016) 0.85
Immunotherapy: The path to win the war on cancer? Cell (2015) 0.84
Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015. J Transl Med (2016) 0.82
The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference. J Immunol (2016) 0.82
Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma. J Immunother Cancer (2015) 0.82
Somatic Variation of T-Cell Receptor Genes Strongly Associate with HLA Class Restriction. PLoS One (2015) 0.82
Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes. Nat Biotechnol (2016) 0.81
Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor. Cancer Immunol Res (2016) 0.81
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials. J Immunother Cancer (2016) 0.81
Characteristics of Tumor Infiltrating Lymphocyte and Circulating Lymphocyte Repertoires in Pancreatic Cancer by the Sequencing of T Cell Receptors. Sci Rep (2015) 0.81
T cell receptor β-chain repertoire analysis reveals intratumour heterogeneity of tumour-infiltrating lymphocytes in oesophageal squamous cell carcinoma. J Pathol (2016) 0.80
Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens. Front Immunol (2015) 0.80
Direct measurement of T cell receptor affinity and sequence from naïve antiviral T cells. Sci Transl Med (2016) 0.80
Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection. Transpl Int (2010) 0.79
Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes. Cancer Immunol Immunother (2005) 0.79
Reversible Oligonucleotide Chain Blocking Enables Bead Capture and Amplification of T-Cell Receptor α and β Chain mRNAs. J Am Chem Soc (2016) 0.79
Multiplex Identification of Antigen-Specific T Cell Receptors Using a Combination of Immune Assays and Immune Receptor Sequencing. PLoS One (2015) 0.78
Diversity and divergence of the glioma-infiltrating T-cell receptor repertoire. Proc Natl Acad Sci U S A (2016) 0.78
Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR. Proc Natl Acad Sci U S A (2016) 0.78
Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity. Cancer Res (2016) 0.77
Increased incidence of head and neck cancer in liver transplant recipients: a meta-analysis. BMC Cancer (2014) 0.77
Donor transmission of malignant melanoma to a liver graft recipient: case report and literature review. Clin Transplant (2009) 0.77
DNA demethylating agent decitabine broadens the peripheral T cell receptor repertoire. Oncotarget (2016) 0.76
T cell receptor diversity in the human thymus. Mol Immunol (2016) 0.75
Next-generation TCR sequencing - a tool to understand T-cell infiltration in human cancers. J Pathol (2016) 0.75
Single-cell TCRseq: paired recovery of entire T-cell alpha and beta chain transcripts in T-cell receptors from single-cell RNAseq. Genome Med (2016) 0.75
Pre-T-cell receptor binds MHC: Implications for thymocyte signaling and selection. Proc Natl Acad Sci U S A (2015) 0.75
Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies. Mol Clin Oncol (2016) 0.75
TCRβ repertoire of CD4+ and CD8+ T cells is distinct in richness, distribution, and CDR3 amino acid composition. J Leukoc Biol (2015) 0.75
Evaluation of TCR repertoire diversity in patients after hematopoietic stem cell transplantation. Stem Cell Investig (2015) 0.75
SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma. Oncotarget (2016) 0.75
Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma. Sci Rep (2016) 0.75
Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma. Sci Rep (2017) 0.75
MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivo. J Cancer Res Clin Oncol (2017) 0.75